175 related articles for article (PubMed ID: 9199199)
1. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding.
Wang H; Toida T; Kim YS; Capila I; Hileman RE; Bernfield M; Linhardt RJ
Biochem Biophys Res Commun; 1997 Jun; 235(2):369-73. PubMed ID: 9199199
[TBL] [Abstract][Full Text] [Related]
2. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
3. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
[TBL] [Abstract][Full Text] [Related]
4. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
5. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
[TBL] [Abstract][Full Text] [Related]
6. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors.
Westergren-Thorsson G; Persson S; Isaksson A; Onnervik PO; Malmström A; Fransson LA
Exp Cell Res; 1993 May; 206(1):93-9. PubMed ID: 7683278
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
[TBL] [Abstract][Full Text] [Related]
8. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro.
Mueller SN; Thomas KA; Di Salvo J; Levine EM
J Cell Physiol; 1989 Sep; 140(3):439-48. PubMed ID: 2777882
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
10. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.
Hallak LK; Collins PL; Knudson W; Peeples ME
Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881
[TBL] [Abstract][Full Text] [Related]
11. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor.
Foxall C; Holme KR; Liang W; Wei Z
Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987
[TBL] [Abstract][Full Text] [Related]
12. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK
Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005
[TBL] [Abstract][Full Text] [Related]
13. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.
Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM
Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356
[TBL] [Abstract][Full Text] [Related]
14. Differential scanning fluorimetry measurement of protein stability changes upon binding to glycosaminoglycans: a screening test for binding specificity.
Uniewicz KA; Ori A; Xu R; Ahmed Y; Wilkinson MC; Fernig DG; Yates EA
Anal Chem; 2010 May; 82(9):3796-802. PubMed ID: 20353159
[TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
Alberdi E; Hyde CC; Becerra SP
Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms for the regulation of growth factor binding by heparin.
Forsten KE; Fannon M; Nugent MA
J Theor Biol; 2000 Jul; 205(2):215-30. PubMed ID: 10873433
[TBL] [Abstract][Full Text] [Related]
17. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
[TBL] [Abstract][Full Text] [Related]
18. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
Hausser H; Kresse H
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
[TBL] [Abstract][Full Text] [Related]
19. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
20. Chemical sulfonation and anticoagulant activity of acharan sulfate.
Wu SJ; Chun MW; Shin KH; Toida T; Park Y; Linhardt RJ; Kim YS
Thromb Res; 1998 Dec; 92(6):273-81. PubMed ID: 9870894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
